Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007 [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety, tolerability, and pharmacokinetics of single and multiple ascending oral doses of iQ-007 in epilepsy patients, including drug-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• iQ-007

Snippet

Sponsor: iQure Australia Pty Ltd | Conditions: Drug Resistant Epilepsy, Focal Seizure | Phase 1 | Status: ACTIVE_NOT_RECRUITING